# Volatile Markers in Digestive Cancer

> **NCT02332213** · — · COMPLETED · sponsor: **University of Latvia** · enrollment: 2022 (actual)

## Conditions studied

- Colorectal Cancer
- Colorectal Adenoma
- Gastric Cancer
- Peptic Ulcer Disease
- Atrophic Gastritis
- Intestinal Metaplasia
- H.Pylori Infection
- Normal Control
- Average-risk General Population

## Interventions

- **PROCEDURE:** Breath sampling for volatile marker detection
- **PROCEDURE:** Upper endoscopy with biopsies
- **PROCEDURE:** Colonoscopy with biopsies or lesion removal when required
- **PROCEDURE:** Plasma/serum sampling
- **PROCEDURE:** Faecal sample acquisition
- **PROCEDURE:** Histological evaluation of the surgery material

## Key facts

- **NCT ID:** NCT02332213
- **Lead sponsor:** University of Latvia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2017-06-30
- **Final completion:** 2017-06-30
- **Target enrollment:** 2022 (ACTUAL)
- **Last updated:** 2018-08-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02332213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02332213, "Volatile Markers in Digestive Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02332213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*